Your browser doesn't support javascript.
loading
Leveraging Rational Protein Engineering to Improve mRNA Therapeutics.
Farelli, Jeremiah D; Asrani, Kirtika H; Isaacs, Cleo; deBear, Joanna S; Stahley, Mary R; Shah, Anumeha; Lasaro, Melissa A; Cheng, Christopher J; Subramanian, Romesh R.
Afiliación
  • Farelli JD; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts.
  • Asrani KH; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts.
  • Isaacs C; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts.
  • deBear JS; 2 Nucleic Acid Technology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut.
  • Stahley MR; 2 Nucleic Acid Technology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut.
  • Shah A; 3 Preclinical Pharmacology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut.
  • Lasaro MA; 3 Preclinical Pharmacology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut.
  • Cheng CJ; 2 Nucleic Acid Technology, Alexion Pharmaceuticals, Inc. , New Haven, Connecticut.
  • Subramanian RR; 1 Discovery Research, Alexion Pharmaceuticals, Inc. , Cambridge, Massachusetts.
Nucleic Acid Ther ; 28(2): 74-85, 2018 04.
Article en En | MEDLINE | ID: mdl-29437538

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arginasa / ARN Mensajero / Hiperargininemia / Hipoxantina Fosforribosiltransferasa / Síndrome de Lesch-Nyhan Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Nucleic Acid Ther Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Arginasa / ARN Mensajero / Hiperargininemia / Hipoxantina Fosforribosiltransferasa / Síndrome de Lesch-Nyhan Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Nucleic Acid Ther Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos